Dec 2, 2009
By:
Andrew Sheivachman
A new study of industry tax professionals conducted by PricewaterhouseCoopers predicts higher taxes for Big Pharma in the wake of the global economic downturn. What can your company do to remain competitive and discover new incentives?
|
Nov 24, 2009
By:
Andrew Sheivachman
Feds targeted 136 Web sites offering foreign or unapproved drugs as part of International Internet Week of Action. But does the FDA campaign ignore a larger crisis endangering consumers?
|
Nov 18, 2009
By:
Andrew Sheivachman
Dubbed as the 'female Viagra,' Boehringer Ingelheim's filbanserin represents an unprecedented step forward in treating female sexual dysfunction.
|
Nov 11, 2009
By:
Andrew Sheivachman
Developing countries will receive the scarce vaccine for free, as GSK remains confident it will fulfill contractual vaccine obligations around the world.
|
Oct 28, 2009
By:
Andrew Sheivachman
Sure, prescription information for Sanofi-Aventis's Uroxatral appears on the back of the tent card, but how can consumer?s see it if it's mounted to a pharmacy wall?
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
